1. Home
  2. OVBC vs IMUX Comparison

OVBC vs IMUX Comparison

Compare OVBC & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

N/A

Current Price

$46.86

Market Cap

212.7M

Sector

Finance

ML Signal

N/A

Logo Immunic Inc.

IMUX

Immunic Inc.

N/A

Current Price

$13.11

Market Cap

209.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OVBC
IMUX
Founded
1872
2016
Country
United States
United States
Employees
N/A
66
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.7M
209.2M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
OVBC
IMUX
Price
$46.86
$13.11
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$36.00
AVG Volume (30 Days)
26.9K
196.4K
Earning Date
04-28-2026
05-14-2026
Dividend Yield
2.22%
N/A
EPS Growth
42.67
38.00
EPS
1.53
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$30.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.18
$0.51
52 Week High
$51.25
$17.43

Technical Indicators

Market Signals
Indicator
OVBC
IMUX
Relative Strength Index (RSI) 65.93 28.95
Support Level $46.54 $11.21
Resistance Level $47.12 $15.82
Average True Range (ATR) 1.17 1.17
MACD 0.18 -0.43
Stochastic Oscillator 84.96 7.58

Price Performance

Historical Comparison
OVBC
IMUX

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Share on Social Networks: